Skip to main content

Table 3 Chemotherapy compliance after lobectomy by different approach

From: Video-assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non-small cell lung cancer

 

VATS

n = 54

Thoracotomy

n = 56

p value

Chemotherapy regimens, no. (%)

  

0.577

   Gemcitabine+Cisplatin

25 (46.3)

29 (51.8)

 

   Paclitaxol+Carboplatin

22(40.7)

23(41.1)

 

   Vinorelbine+Cisplatin

7(13.0)

4(7.1)

 

Time to initiate chemotherapy(days)

33.7 ± 10.9

34.0 ± 13.3

0.904

Cycles completed, (Mean ± SD)

3.6 ± 0.72

3.0 ± 1.1

0.002*

Pts. Receive full dose on schedule, no. (%)

31 (57.4)

19 (33.9)

0.013

Pts. Receive ≥75% planed dose, no. (%)

48(88.9)

40(71.4)

0.022*

Mean doses, (% of planed)

   

   Cisplatin (mg/m2)

267 (89.0)

237 (79.0)

0.121

   Gemcitabine (mg/m2)

8900 (9.0)

7930 (79.3)

0.120

   Paclitaxol (mg/m2)

620 (88.6)

495 (70.7)

0.020*

   Carboplatin (AUC mg/ml/min)

21.3 (88.8)

17.0 (70.8)

0.019*

Toxicity, no. (%)

  

0.011*

   Grade 1/2 toxicity

25 (46.3)

34 (60.7)

0.130

   Grade 3/4 toxicity

11 (20.4)

20 (35.7)

0.074